Carillon Tower Advisers’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $44.9M | Buy |
+263,301
| New | +$44.9M | 0.27% | 114 |
|
|
2020
Q3 | – | Sell |
-339,743
| Closed | -$54.5M | – | 486 |
|
|
2020
Q2 | $54.5M | Hold |
339,743
| – | – | 0.42% | 76 |
|
|
2020
Q1 | $31.6M | Hold |
339,743
| – | – | 0.31% | 116 |
|
|
2019
Q4 | $43.8M | Hold |
339,743
| – | – | 0.29% | 119 |
|
|
2019
Q3 | $25.6M | Sell |
339,743
-190,932
| -36% | -$14.4M | 0.18% | 207 |
|
|
2019
Q2 | $80.6M | Sell |
530,675
-82,535
| -13% | -$12.5M | 0.55% | 40 |
|
|
2019
Q1 | $80.6M | Sell |
613,210
-215,827
| -26% | -$28.4M | 0.57% | 29 |
|
|
2018
Q4 | $90.5M | Buy |
829,037
+11,121
| +1% | +$1.21M | 0.77% | 12 |
|
|
2018
Q3 | $132M | Buy |
817,916
+295,582
| +57% | +$47.7M | 0.95% | 6 |
|
|
2018
Q2 | $69M | Sell |
522,334
-173,570
| -25% | -$22.9M | 0.54% | 42 |
|
|
2018
Q1 | $50M | Hold |
695,904
| – | – | 0.39% | 76 |
|
|
2017
Q4 | $38.7K | Buy |
+695,904
| New | +$38.7K | 0.41% | 85 |
|